Incuron is Led by Experienced and Successful Drug
Development Team

Kristina Zakurdaeva, MD, PhD (CEO)

Hematologist with 10 years experience in the international pharma industry and innovative projects development

Langdon Miller, MD (clinical strategy and operations)

Medical oncologist with > 20 years of experience and major roles in development of Neupogen®, Leukine®, Camptosar®, Elence®, Aromasin®, Sutent®, and Zydelig®

Andrei Gudkov, PhD, D.Sci (science)

Internationally recognized cancer researcher , expert in anticancer drug discovery (>50 US patents), co-inventor of curaxin technology, SVP of Basic Science at RPCI

Ann Hards, PhD (regulatory affairs)

Regulatory expert with major roles in 14 NDA/BLA approvals including Lipitor®, Plavix®, Avapro®, Avalide®, Arixtra®, Fragmin®, Rezulin®, and Multaq®

Andrei Purmal, PhD (pre-clinical, CMC, bioanalytical)

20 years of experience in all aspects of drug development, expert in small molecule CMC and bioanalytical development, co-inventor of curaxin technology